Market Capitalization of Alembic Pharmaceuticals (APLLTD)
As of April 30, 2026, Alembic Pharmaceuticals (APLLTD) market capitalisation is ₹14927.00 Cr ($1.66B), with 19.77 Cr shares outstanding at a current price of ₹755.00 on NSE, ranking 434 out of 5362 companies by market cap in our screener. Alembic Pharmaceuticals operates in the Healthcare sector and is classified as a Mid Cap stock. For live price, earnings and the complete company profile, see Alembic Pharmaceuticals share price chart.
Market Cap History of Alembic Pharmaceuticals (Last 10 Years)
APLLTD market capitalisation from year-end NSE closing prices over the last 10 years. Browse APLLTD financial statements for revenue, profit, balance sheet and cash flow data.
End of Year Market Cap History — Alembic Pharmaceuticals
APLLTD year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Review APLLTD earnings valuation to evaluate earnings-based valuation against sector peers.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹14927.00 Cr
$1.66B USD
|
₹755.00 | NSE | -10.77% |
| 2025 |
₹16729.11 Cr
$1.86B USD
|
₹846.15 | NSE | -20.64% |
| 2024 |
₹21080.68 Cr
$2.34B USD
|
₹1066.25 | NSE | +40.41% |
| 2023 |
₹15013.99 Cr
$1.67B USD
|
₹759.40 | NSE | +32.55% |
| 2022 |
₹11326.73 Cr
$1.26B USD
|
₹572.90 | NSE | -28.56% |
| 2021 |
₹15854.25 Cr
$1.76B USD
|
₹801.90 | NSE | -22.43% |
| 2020 |
₹20438.13 Cr
$2.27B USD
|
₹1033.75 | NSE | +80.95% |
| 2019 |
₹11295.09 Cr
$1.26B USD
|
₹571.30 | NSE | -4.74% |
| 2018 |
₹11856.59 Cr
$1.32B USD
|
₹599.70 | NSE | +13.02% |
| 2017 |
₹10490.42 Cr
$1.17B USD
|
₹530.60 | NSE | -10.84% |
| 2016 |
₹11765.64 Cr
$1.31B USD
|
₹595.10 | NSE | -14.50% |
| 2015 |
₹13761.51 Cr
$1.53B USD
|
₹696.05 | NSE | +56.36% |
| 2014 |
₹8801.00 Cr
$977.89M USD
|
₹445.15 | NSE | +110.87% |
| 2013 |
₹4173.63 Cr
$463.74M USD
|
₹211.10 | NSE | +191.17% |
| 2012 |
₹1433.39 Cr
$159.27M USD
|
₹72.50 | NSE | +104.51% |
| 2011 |
₹700.88 Cr
$77.88M USD
|
₹35.45 | NSE | - |